VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
40 hedge funds and large institutions have $9.58M invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
Holders
40
Holding in Top 10
1
Calls
$6K
Puts
–
Top Buyers
| 1 | +$36.9K | |
| 2 | +$24.1K | |
| 3 | +$17.9K | |
| 4 |
WA
WealthTrust Axiom
Wayne,
Pennsylvania
|
+$11.6K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
+$8.81K |
Top Sellers
| 1 | -$172K | |
| 2 | -$145K | |
| 3 | -$57.8K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$54.2K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$23.6K |